Aster DM Healthcare Ltd (ASTERDM) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Aster DM Healthcare reported strong 9M FY25 results, driven by capacity expansion, ARPOB enhancement, and cost optimization.
- Revenue grew by 15% YoY to INR 3,138 crore, fueled by a 12% rise in ARPOB and a 4% increase in occupied beds.
- Operating EBITDA surged by 35% to INR 613 crore, with margins expanding to 19.5% from 16.6% in 9M FY24.
- Adjusted net profit increased by 65% to INR 251 crore, boosted by operational strength and higher other income.
- The merger with Quality Care India Limited (QCIL) is progressing, with shareholder approval secured and applications filed with regulatory bodies.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.